Zobrazeno 1 - 10
of 94
pro vyhledávání: '"Ramona F Swaby"'
Autor:
Yuan Yuan, Michael Klichinsky, Saar Gill, Melissa Johnson, Thomas Condamine, Jennifer Specht, Richard T Maziarz, Kim Reiss, Debora Barton, Daniel Cushing, Joanne Mortimer, Paula R Pohlmann, E Claire Dees, Naoto Ueno, Mathew Angelos, Ramona F Swaby, Yara Abdou
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/ac9f82ba4b6e4214881cf6857a725f08
Autor:
Alvaro N.A. Monteiro, Paolo Radice, Fergus J. Couch, David Goldgar, Andrej Sali, Katherine L. Nathanson, Jennifer L. Pickard-Brzosowicz, Rebecca Sutphen, Lisa Baumbach, Luis Gayol, Rosane Silva, Edson Rondinelli, Turan P. Urmenyi, Ramona F. Swaby, Scott Grist, Siranoush Manoukian, Rachel Karchin, Sylvia M. Marsillac, Marcelo A. Carvalho
Supplementary Figure S1 from Determination of Cancer Risk Associated with Germ Line BRCA1 Missense Variants by Functional Analysis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44ce0036825ece5365bf7d68660751d0
https://doi.org/10.1158/0008-5472.22365647
https://doi.org/10.1158/0008-5472.22365647
Autor:
Alvaro N.A. Monteiro, Paolo Radice, Fergus J. Couch, David Goldgar, Andrej Sali, Katherine L. Nathanson, Jennifer L. Pickard-Brzosowicz, Rebecca Sutphen, Lisa Baumbach, Luis Gayol, Rosane Silva, Edson Rondinelli, Turan P. Urmenyi, Ramona F. Swaby, Scott Grist, Siranoush Manoukian, Rachel Karchin, Sylvia M. Marsillac, Marcelo A. Carvalho
Germ line inactivating mutations in BRCA1 confer susceptibility for breast and ovarian cancer. However, the relevance of the many missense changes in the gene for which the effect on protein function is unknown remains unclear. Determination of which
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24fa242ae6438f98342595e9d819befa
https://doi.org/10.1158/0008-5472.c.6494798.v1
https://doi.org/10.1158/0008-5472.c.6494798.v1
Autor:
Rene Gonzalez Mendoza, Burak Gumuscu, P. Zhang, Nicole Basset-Seguin, Brett G.M. Hughes, Abhishek Joshi, Jean-Jacques Grob, Diana Chirovsky, Nicolas Meyer, Ramona F. Swaby, Josep M. Piulats, Olga Vornicova, Florent Grange, Jacob Schachter, Jessica Bauman
Publikováno v:
Dermatology and Therapy
Introduction Pembrolizumab provided durable responses and acceptable safety in recurrent or metastatic (R/M) cutaneous squamous cell carcinoma (cSCC) in the KEYNOTE-629 study. In this elderly, fragile population with disfiguring tumours, preservation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1aa5f49597bf3ebbb73fee8323b8178e
http://europepmc.org/articles/PMC8484388
http://europepmc.org/articles/PMC8484388
Autor:
Kevin J. Harrington, Barbara Burtness, Richard Greil, Denis Soulières, Makoto Tahara, Gilberto de Castro, Amanda Psyrri, Irene Brana, Neus Basté, Prakash Neupane, Åse Bratland, Thorsten Fuereder, Brett G.M. Hughes, Ricard Mesia, Nuttapong Ngamphaiboon, Tamara Rordorf, Wan Zamaniah Wan Ishak, Jianxin Lin, Burak Gumuscu, Ramona F. Swaby, Danny Rischin
Publikováno v:
Scientia
PURPOSE Pembrolizumab and pembrolizumab-chemotherapy demonstrated efficacy in recurrent/metastatic head and neck squamous cell carcinoma in KEYNOTE-048. Post hoc analysis of long-term efficacy and progression-free survival on next-line therapy (PFS2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ecb2be241c70ef569c84015a1a2507e2
https://pubmed.ncbi.nlm.nih.gov/36219809
https://pubmed.ncbi.nlm.nih.gov/36219809
Autor:
Barbara Burtness, Danny Rischin, Richard Greil, Denis Soulières, Makoto Tahara, Gilberto de Castro Jr, Amanda Psyrri, Irene Brana, Neus Basté, Prakash Neupane, Åse Bratland, Thorsten Fuereder, Brett G.M. Hughes, Ricard Mesia, Nuttapong Ngamphaiboon, Tamara Rordorf, Wan Zamaniah Wan Ishak, Joy Ge, Ramona F. Swaby, Burak Gumuscu, Kevin Harrington
Publikováno v:
Scientia
Quimioteràpia; Carcinoma de cèl·lules escamoses de cap i coll Quimioterapia; Carcinoma de células escamosas de cabeza y cuello Chemotherapy; Head and neck squamous cell carcinoma PURPOSE The phase III KEYNOTE-048 (ClinicalTrials.gov identifier: N
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c375dae4601616617fa1f77895fd15e
https://hdl.handle.net/11351/7984
https://hdl.handle.net/11351/7984
Autor:
Shunji Takahashi, Nobuhiko Oridate, Kaoru Tanaka, Yasushi Shimizu, Yasushi Fujimoto, Koji Matsumoto, Tomoya Yokota, Tomoko Yamazaki, Masanobu Takahashi, Tsutomu Ueda, Nobuhiro Hanai, Hironori Yamaguchi, Hiroki Hara, Tomokazu Yoshizaki, Ryuji Yasumatsu, Masahiro Nakayama, Kiyoto Shiga, Takashi Fujii, Kenji Mitsugi, Kenichi Takahashi, Nijiro Nohata, Burak Gumuscu, Ramona F. Swaby, Makato Tahara
Publikováno v:
International journal of clinical oncology. 27(12)
Background Here, we report the results of the Japanese subgroup of the phase 3 KEYNOTE-048 study of pembrolizumab alone, pembrolizumab plus platinum and 5-fluorouracil (pembrolizumab–chemotherapy), or cetuximab plus platinum and 5-fluorouracil (EXT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38dabf5412c2407d6aac777a1fea51fe
https://pubmed.ncbi.nlm.nih.gov/36264378
https://pubmed.ncbi.nlm.nih.gov/36264378
Autor:
Thao T Vo, Janet L Espirito, Marley Boyd, Burak Gumuscu, Diana Chirovsky, Nicholas J Robert, Ramona F Swaby, Wei Zhou, Charles Lance Cowey
Publikováno v:
Future oncology (London, England). 18(17)
Aim: Real-world treatment patterns and clinical outcomes in advanced cutaneous squamous cell carcinoma were evaluated. Methods: Adults receiving their first systemic therapy for unresectable, locally advanced or recurrent/metastatic cutaneous squamou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e143f10aa73ee1dc0637777b8f5365b5
https://pubmed.ncbi.nlm.nih.gov/35240857
https://pubmed.ncbi.nlm.nih.gov/35240857
Autor:
Kim A. Reiss, Yuan Yuan, Naoto T. Ueno, Yara Abdou, Debora Barton, Ramona F. Swaby, Amy Ronczka, Daniel J. Cushing, Sascha Abramson, Thomas Condamine, Michael Klichinsky, E. Claire Dees
Publikováno v:
Cancer Research. 82:CT524-CT524
Background: Adoptive T cell therapies have led to remarkable advances in hematologic cancers but with less effect in ST. Actively recruited tumor associated macrophages (TAM) are abundant in the ST microenvironment (TME) and typically display immunos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b88d888fe248041c01fed8e42ee625bb
https://doi.org/10.1158/1538-7445.am2022-ct524
https://doi.org/10.1158/1538-7445.am2022-ct524
Autor:
Kim Anna Reiss, Yuan Yuan, Naoto T. Ueno, Melissa Lynne Johnson, Saar Gill, Elizabeth Claire Dees, Joseph Chao, Mathew Angelos, Olga Shestova, Jonathan Stuart Serody, Saul Priceman, Debora Barton, Ramona F. Swaby, Amy Ronczka, Thomas Condamine, Daniel Cushing, Rehman Qureshi, Madison Kemp, Michael Klichinsky, Yara Abdou
Publikováno v:
Journal of Clinical Oncology. 40:2533-2533
2533 Background: Most solid tumors are resistant to immunotherapy. In pre-clinical studies, CAR-M infiltrate tumors, phagocytose tumor cells, activate the tumor micro environment (TME), recruit T cells, and present tumor antigens to T cells leading t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::101fafb24806863161f5a0899f2a05c2
https://doi.org/10.1200/jco.2022.40.16_suppl.2533
https://doi.org/10.1200/jco.2022.40.16_suppl.2533